2018 AGITG Innovation Fund – Applications close 20 August
Applications are open until 20 August for the AGITG Innovation Fund. The Innovation Fund is made... Read More
AGITG Trial News
Trial news: The AGITG currently has eleven studies open to recruitment and four studies in follow up. The table below... Read More
CAP members Gill Worden & Jan Mumford: Going above and beyond for research
Gill Worden and Jan Mumford, members of the AGITG’s Consumer Advisory Panel (CAP), will both trek 60km for... Read More
Gastrointestinal Stromal Tumour Trials and Regorafenib Access Program
This information was prepared for AGITG members by Professor Desmond Yip and Professor John Zalcberg. There are now a... Read More
Our Research Priorities: What is key to the future of research?
During 2017 our Board of Directors and management created a revised Strategic Plan for the organisation and its... Read More
DYNAMIC-Rectal: Using blood tests to make chemotherapy decisions
The DYNAMIC-Rectal trial has opened to recruitment. This trial is analysing the presence of circulating tumour DNA (ctDNA)... Read More
Dr Danielle Ferraro: How the Kristian Anderson Award enabled my research
Dr Danielle Ferraro from the University of Melbourne was the recipient of the inaugural Merck-AGITG Kristian Anderson Award... Read More
SPAR trial awarded $1.2m grant
The SPAR trial, which opened to recruitment in May this year, has received a $1.2 million grant from... Read More
Patient preferences for chemotherapy presented at ASCO
An AGITG sub-study presented at the world’s largest oncology meeting shows the way people with colorectal cancer make... Read More
The latest global developments in GI cancer from the ASCO Annual Meeting
More than 32,000 oncology professionals from around the world attended the ASCO Annual Meeting in June, presenting and... Read More
SCOT trial recognised for finding that chemotherapy courses could be halved
The SCOT trial is gaining international attention for its findings that three months of chemotherapy could be as... Read More
Summary of the 2018 Open Working Party Meetings
On 11 May, the AGITG held its Annual General Meeting coinciding with an Open Working Parties Meeting. The Working... Read More
Watch: Highlights of the Mt Aconcagua Gutsy Challenge
In December 2017, eight trekkers climbed Mt Aconcagua in Argentina to raise awareness and much-needed funds for digestive... Read More
Worldwide call for all cancer patients to be prescribed exercise
The Clinical Oncology Society of Australia (COSA) has released a position statement on ‘Exercise in Cancer Care’. Highlighted... Read More
SPAR trial investigates the use of cholesterol medication in cancer treatment
The SPAR trial, which will test the effect of cholesterol medication on the treatment of patients with rectal... Read More
CONTROL NETs Recognised With $200,000 Grant
A $200,000 grant has been secured by the Unicorn Foundation for the CONTROL NETs study, which is providing... Read More
AGITG Outstanding Site Award
Clinical trial sites actively involved in AGITG studies are invited to apply for the prestigious AGITG Outstanding Site... Read More
The 2018 Merck-AGITG Kristian Anderson Award
NOTE: Applications for this award have now closed. The Merck-AGITG Kristian Anderson Award supports a clinician undertaking a higher... Read More
The 2018 John Zalcberg OAM Award for Excellence in AGITG Research
Note: Applications for this award have now closed. The John Zalcberg OAM Award for Excellence in AGITG Research recognises... Read More
Recruitment continues for NABNEC
Recruitment continues to progress for the NABNEC trial. The trial opened last year with participating centres in... Read More